Yi‐Hsin Weng

A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan

Alessio Di Fonzo, Yah‐Huei Wu‐Chou, Chin-Song Lu et al. · Neurogenetics · 2006 · 228 citations

Life Sciences, Genetics, Molecular Genetics +15

PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons

Hung‐Li Wang, An-Hsun Chou, Ai-Shun Wu et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2011 · 122 citations · Full text

Life Sciences, Genetics, Neuroscience +17

HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3

An-Hsun Chou, Si-Ying Chen, Tu‐Hsueh Yeh et al. · Neurobiology of Disease · 2010 · 95 citations · Full text

Life Sciences, Genetics, Molecular Biology +8

<i>PLA2G6</i> mutations in PARK14‐linked young‐onset parkinsonism and sporadic Parkinson's disease

Chin‐Song Lu, Szu‐Chia Lai, Ruey‐Meei Wu et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2011 · 79 citations

Life Sciences, Genetics, Neurology +15

(G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse

Jun-Shiao Chou, Chuyu Chen, Ying‐Ling Chen et al. · Neurobiology of Disease · 2014 · 79 citations · Full text

Life Sciences, Neurobiology, Neuroscience +15